654 related articles for article (PubMed ID: 11296948)
1. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
Seitz M; Zwicker M; Wider B
J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
3. Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction.
Constantin A; Loubet-Lescoulié P; Lambert N; Yassine-Diab B; Abbal M; Mazières B; de Préval C; Cantagrel A
Arthritis Rheum; 1998 Jan; 41(1):48-57. PubMed ID: 9433869
[TBL] [Abstract][Full Text] [Related]
4. Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis: correlation with skin reactions.
Ernestam S; Lampa J; Rogberg S; Rönnelid J; Klareskog L; Hafström I
J Rheumatol; 2003 Aug; 30(8):1748-55. PubMed ID: 12913930
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment.
Wijngaarden S; van Roon JA; van de Winkel JG; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2005 Jun; 44(6):729-34. PubMed ID: 15757966
[TBL] [Abstract][Full Text] [Related]
6. In vitro modulation of cytokine, cytokine inhibitor, and prostaglandin E release from blood mononuclear cells and synovial fibroblasts by antirheumatic drugs.
Seitz M; Loetscher P; Dewald B; Towbin H; Baggiolini M
J Rheumatol; 1997 Aug; 24(8):1471-6. PubMed ID: 9263137
[TBL] [Abstract][Full Text] [Related]
7. Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes.
Seitz M; Zwicker M; Loetscher P
Arthritis Rheum; 1998 Nov; 41(11):2032-8. PubMed ID: 9811059
[TBL] [Abstract][Full Text] [Related]
8. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells.
van den Borne BE; Dijkmans BA; de Rooij HH; le Cessie S; Verweij CL
J Rheumatol; 1997 Jan; 24(1):55-60. PubMed ID: 9002011
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis.
Schotte H; Schlüter B; Willeke P; Mickholz E; Schorat MA; Domschke W; Gaubitz M
Rheumatology (Oxford); 2004 Aug; 43(8):960-4. PubMed ID: 15026584
[TBL] [Abstract][Full Text] [Related]
10. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
[TBL] [Abstract][Full Text] [Related]
11. Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX.
Fiehn C; Müller-Ladner U; Gay S; Krienke S; Freudenberg-Konrad S; Funk J; Ho AD; Sinn H; Wunder A
Rheumatology (Oxford); 2004 Sep; 43(9):1097-105. PubMed ID: 15199219
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
[TBL] [Abstract][Full Text] [Related]
13. Effects of methotrexate on the expression of the translational isoforms of glucocorticoid receptors α and β: correlation with methotrexate efficacy in rheumatoid arthritis patients.
Gatica H; Aliste M; Guerrero J; Goecke IA
Rheumatology (Oxford); 2011 Sep; 50(9):1665-71. PubMed ID: 21642336
[TBL] [Abstract][Full Text] [Related]
14. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
[TBL] [Abstract][Full Text] [Related]
15. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
16. A novel predictor of clinical response to methotrexate in patients with rheumatoid arthritis: a pilot study of in vitro T cell cytokine suppression.
Haroon N; Srivastava R; Misra R; Aggarwal A
J Rheumatol; 2008 Jun; 35(6):975-8. PubMed ID: 18464312
[TBL] [Abstract][Full Text] [Related]
17. Effects of gold on cytokine production in vitro; increase of monocyte dependent interleukin 10 production and decrease of interferon-gamma levels.
Lampa J; Klareskog L; Rönnelid J
J Rheumatol; 2002 Jan; 29(1):21-8. PubMed ID: 11824965
[TBL] [Abstract][Full Text] [Related]
18. Enhanced production of tissue inhibitor of metalloproteinases by peripheral blood mononuclear cells of rheumatoid arthritis patients responding to methotrexate treatment.
Seitz M; Dayer JM
Rheumatology (Oxford); 2000 Jun; 39(6):637-45. PubMed ID: 10888709
[TBL] [Abstract][Full Text] [Related]
19. Mononuclear cell response to lipopolysaccharide in patients with rheumatoid arthritis: relationship with tristetraprolin expression.
Fabris M; Tolusso B; Di Poi E; Tomietto P; Sacco S; Gremese E; Ferraccioli G
J Rheumatol; 2005 Jun; 32(6):998-1005. PubMed ID: 15940758
[TBL] [Abstract][Full Text] [Related]
20. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis.
Rizzo R; Rubini M; Govoni M; Padovan M; Melchiorri L; Stignani M; Carturan S; Ferretti S; Trotta F; Baricordi OR
Pharmacogenet Genomics; 2006 Sep; 16(9):615-23. PubMed ID: 16906016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
